Stocks Comparison
Caris Life Sciences vs Natera: revenue, profit, margins and growth compared
Caris Life Sciences brought in $812M of revenue in fiscal 2025, Natera $2.3B in fiscal 2025. Revenue changed by +97.0% at Caris Life Sciences and +35.9% at Natera on the year before, so Caris Life Sciences grew faster. Caris Life Sciences kept -8.4% of its revenue as net profit, Natera -9.0%. Free cash flow was $66.9M at Caris Life Sciences and $109.1M at Natera.
Side by side, latest fiscal year
| CAI | NTRA | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $812M | $2.3B |
| Revenue growth | +97.0% | +35.9% |
| Net income | -$68.1M | -$208.2M |
| Net margin | -8.4% | -9.0% |
| Free cash flow | $66.9M | $109.1M |
| Free cash flow margin | 8.2% | 4.7% |
| Earnings per share (diluted) | -$3.22 | -$1.52 |
| Cash | $796.3M | $1.1B |
| Debt | $378.5M | n/a |
| Price to earnings | n/a | n/a |
| Market value | $9B | $59.5B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #161 of 523 · Health care | #101 of 523 · Health care |
Over the years
Questions about Caris Life Sciences and Natera
Which is bigger by revenue, Caris Life Sciences or Natera?
Natera is bigger by revenue: $2.3B in fiscal 2025, against $812M for Caris Life Sciences in fiscal 2025.
Which keeps more of its revenue as profit, Caris Life Sciences or Natera?
Caris Life Sciences had a net margin of -8.4% in fiscal 2025; Natera had -9.0% in fiscal 2025.
Which grew revenue faster, Caris Life Sciences or Natera?
In their latest fiscal years revenue changed by +97.0% at Caris Life Sciences and +35.9% at Natera.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.